Cunningham D - Search Results

1

RAS mutations and cetuximab in locally advanced rectal cancer: results of the EXPERT-C trial.

Sclafani F, Gonzalez D, Cunningham D, Hulkki Wilson S, Peckitt C, Giralt J, Glimelius B, Roselló Keränen S, Wotherspoon A, Brown G, Tait D, Oates J, Chau I. Sclafani F, et al. Among authors: cunningham d. Eur J Cancer. 2014 May;50(8):1430-6. doi: 10.1016/j.ejca.2014.02.002. Epub 2014 Feb 28. Eur J Cancer. 2014. PMID: 24582914 Clinical Trial.

2

Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation.

Tiley C, Powles R, Catalano J, Treleaven J, Eshelby J, Hewetson M, Tait D, Cunningham D. Tiley C, et al. Among authors: cunningham d. Leuk Lymphoma. 1992 Jul;7(4):317-21. doi: 10.3109/10428199209049784. Leuk Lymphoma. 1992. PMID: 1493431 Clinical Trial.

3

Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours.

Ellis PA, Norman A, Hill A, O'Brien ME, Nicolson M, Hickish T, Cunningham D. Ellis PA, et al. Among authors: cunningham d. Eur J Cancer. 1995 Sep;31A(10):1594-8. doi: 10.1016/0959-8049(95)00323-b. Eur J Cancer. 1995. PMID: 7488407 Clinical Trial.

4

Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.

Hill M, Norman A, Cunningham D, Findlay M, Nicolson V, Hill A, Iveson A, Evans C, Joffe J, Nicolson M, et al. Hill M, et al. Among authors: cunningham d. J Clin Oncol. 1995 Jun;13(6):1297-302. doi: 10.1200/JCO.1995.13.6.1297. J Clin Oncol. 1995. PMID: 7751874 Clinical Trial.

5

Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancer.

Findlay M, Hill A, Cunningham D, Norman A, Nicolson M, Ford H, Husband J, Evans C, Carter R. Findlay M, et al. Among authors: cunningham d. Ann Oncol. 1994 Mar;5(3):239-43. doi: 10.1093/oxfordjournals.annonc.a058800. Ann Oncol. 1994. PMID: 8186171 Free article. Clinical Trial.

6

The chemotherapy of colon cancer can no longer be ignored.

Cunningham D, Findlay M. Cunningham D, et al. Eur J Cancer. 1993;29A(15):2077-9. doi: 10.1016/0959-8049(93)90036-f. Eur J Cancer. 1993. PMID: 8297642 Review. No abstract available.

7

Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.

Bamias A, Hill ME, Cunningham D, Norman AR, Ahmed FY, Webb A, Watson M, Hill AS, Nicolson MC, O'Brien ME, Evans TC, Nicolson V. Bamias A, et al. Among authors: cunningham d. Cancer. 1996 May 15;77(10):1978-85. doi: 10.1002/(SICI)1097-0142(19960515)77:10<1978::AID-CNCR3>3.0.CO;2-D. Cancer. 1996. PMID: 8640659 Clinical Trial.

8

Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF).

Andreyev HJ, Norman AR, Cunningham D, Padhani AR, Hill AS, Ross PJ, Webb A. Andreyev HJ, et al. Among authors: cunningham d. Eur J Cancer. 1995 Dec;31A(13-14):2209-14. doi: 10.1016/0959-8049(95)00482-3. Eur J Cancer. 1995. PMID: 8652244

9

The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer.

Webb A, Scott-Mackie P, Cunningham D, Norman A, Andreyev J, O'Brien M, Bensted J. Webb A, et al. Among authors: cunningham d. Eur J Cancer. 1996 Jan;32A(1):63-8. doi: 10.1016/0959-8049(95)00504-8. Eur J Cancer. 1996. PMID: 8695243 Clinical Trial.

10

Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.

Cunningham D. Cunningham D. Eur J Cancer. 1996;32A Suppl 3:S1-8. doi: 10.1016/0959-8049(96)00290-0. Eur J Cancer. 1996. PMID: 8943658 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,205 results

Search Page